1469-896X/asset/olbannerleft.gif?v=1&s=d218899ae53b2862ab119790ed504b8d72122fb3)
1469-896X/asset/olbannerright.gif?v=1&s=59470eb9a1d9b7b13b1be75e9445e6c46ee2214f)
Article
You have full text access to this OnlineOpen article
Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates
Article first published online: 15 JUN 2010
DOI: 10.1002/pro.434
Copyright © 2010 The Protein Society
Additional Information
How to Cite
Franey, H., Brych, S. R., Kolvenbach, C. G. and Rajan, R. S. (2010), Increased aggregation propensity of IgG2 subclass over IgG1: Role of conformational changes and covalent character in isolated aggregates. Protein Science, 19: 1601–1615. doi: 10.1002/pro.434
Publication History
- Issue published online: 23 AUG 2010
- Article first published online: 15 JUN 2010
- Manuscript Accepted: 4 JUN 2010
- Manuscript Revised: 28 MAY 2010
- Manuscript Received: 26 FEB 2010
References
- 1( 2001) Antibody-directed therapy: past, present, and future. J Allergy Clin Immunol 108: S111–S116.
- 2, , , ( 1996) The effect of pH, hydrogen peroxide and temperature on the stability of human monoclonal antibody. J Pharm Biomed Anal 14: 1133–1140.
- 3, , , ( 2008) Effects of solution conditions, processing parameters, and container materials on aggregation of a monoclonal antibody during freeze-thawing. J Pharm Sci 97: 1801–1812.Direct Link:
- 4, , , , ( 2007) Antibody structure, instability, and formulation. J Pharm Sci 96: 1–26.Direct Link:
- 5, ( 2010) Aggregation of a multidomain protein: a coagulation mechanism governs aggregation of a model IgG1 antibody under weak thermal stress. Protein Sci 19: 279–290.Direct Link:
- 6, , , ( 2009) Structural properties of monoclonal antibody aggregates induced by freeze-thawing and thermal stress. Eur J Pharm Sci 38: 79–87.
- 7, ( 2008) Current perspectives on stability of protein drug products during formulation, fill and finish operations. Biotechnol Prog 24: 504–514.Direct Link:
- 8, , , ( 2004) Structure-immunogenicity relationships of therapeutic proteins. Pharm Res 21: 897–903.
- 9, , , ( 2009) Protein aggregation: pathways, induction factors and analysis. J Pharm Sci 98: 2909–2934.Direct Link:
- 10, , , , , , , ( 2000) Thermodynamic modulation of light chain amyloid fibril formation. J Biol Chem 275: 1570–1574.
- 11, , , , , , ( 2007) Quantitation of aggregate levels in a recombinant humanized monoclonal antibody formulation by size-exclusion chromatography, asymmetrical flow field flow fractionation, and sedimentation velocity. J Pharm Sci 96: 268–279.Direct Link:
- 12( 1993) A protein structural approach to the solution of biological problems: alpha 1-antitrypsin as a recent example. Am J Physiol 265: L211–L219.
- 13( 2006) Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem 75: 333–366.
- 14, , , , , , , , , ( 2006) Formation of pyroglutamic acid from N-terminal glutamic acid in immunoglobulin gamma antibodies. Anal Chem 78: 2370–2376.
- 15( 1995) Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. J Chromatogr A 705: 129–134.
- 16, ( 2007) Applications of mass spectrometry for the structural characterization of recombinant protein pharmaceuticals. Mass Spectrom Rev 26: 370–373.Direct Link:
- 17, , , , , , , , , , , , , ( 2008) Structural and functional characterization of disulfide isoforms of the human IgG2 subclass. J Biol Chem 283: 16206–16215.
- 18, , , , , , , , , , et al. ( 2008) Human IgG2 antibodies display disulfide-mediated structural isoforms. J Biol Chem 283: 16194–16205.
- 19, , ( 1968) Structural features of gamma-immunoglobulin, antibody, and their fragments. Circular dichroism studies. Biochemistry 7: 3958–3964.
- 20, ( 1989) Theoretical study of the contribution of aromatic side chains to the circular dichroism of basic bovine pancreatic trypsin inhibitor. Biochemistry 28: 8609–8613.
- 21, , , , , , , , ( 2001) A specific molar ratio of stabilizer to protein is required for storage stability of a lyophilized monoclonal antibody. J Pharm Sci 90: 310–321.Direct Link:
- 22, , , , , ( 1999) Tyrosine, phenylalanine, and disulfide contributions to the circular dichroism of proteins: circular dichroism spectra of wild-type and mutant bovine pancreatic trypsin inhibitor. Biochemistry 38: 10814–10822.
- 23, , ( 1981) Circular dichroism spectroscopy of bovine pancreatic trypsin inhibitor and five altered conformational states. Relationship of conformation and the refolding pathway of the trypsin inhibitor. Biochemistry 20: 5744–5754.
- 24
- 25, ( 2002) Free sulfhydryl in recombinant monoclonal antibodies. Biotechnol Prog 18: 509–513.Direct Link:
- 26, , , ( 2009) Conformational implications of an inversed pH- dependent antibody aggregation. J Pharm Sci 98: 3031–3042.Direct Link:
- 27, , ( 2008) Free sulfhydryl measurement as an indicator of antibody stability. Anal Biochem 382: 66–68.
- 28, , , , , , , ( 2009) Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies. Pharm Res 26: 903–913.
- 29, , , ( 1997) Refined structure of an intact IgG2a monoclonal antibody. Biochemistry 36: 1581–1597.
- 30, , ( 1997) Flexibility of human IgG subclasses. J Immunol 159: 3372–3382.
- 31( 1998) Protein aggregation: folding aggregates, inclusion bodies and amyloid. Fold Des 3: R9–R23.
- 32, ( 1982) A simple method for displaying the hydropathic character of a protein. J Mol Biol 157: 105–132.
- 33, , ( 1990) Protein secondary structures in water from second-derivative amide I infrared spectra. Biochemistry 29: 3303–3308.
- 34, , , , , , ( 2002) Folding and oxidation of the antibody domain C(H)3. J Mol Biol 319: 1267–1277.
- 35, , , , , , , , , ( 2008) Contributions of a disulfide bond to the structure, stability, and dimerization of human IgG1 antibody CH3 domain. Protein Sci 17: 95–106.Direct Link:
- 36, , , , ( 2007) Influence of the internal disulfide bridge on the folding pathway of the CL antibody domain. J Mol Biol 365: 1232–1244.
- 37, , , , , ( 2010) Characterization of antibody aggregation: role of buried, unpaired cysteines in particle formation. J Pharm Sci 99: 764–781.
- 38, , ( 1993) Nondisulfide crosslinking and chemical cleavage of tubulin subunits: pH and temperature dependence. Arch Biochem Biophys 300: 105–114.
- 39, , , ( 2004) Dehydroalanine crosslinks in human lens. Exp Eye Res 79: 499–512.